• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Author Correction: Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification.

作者信息

Lee Miseon, Yoo Tae-Kyung, Chae Byung Joo, Lee Ahwon, Cha Yoon Jin, Lee Jieun, Ahn Sung Gwe, Kang Jun

机构信息

Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Sci Rep. 2025 Mar 10;15(1):8225. doi: 10.1038/s41598-025-92281-5.

DOI:10.1038/s41598-025-92281-5
PMID:40064978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11893746/
Abstract
摘要

相似文献

1
Author Correction: Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification.作者更正：基于三阴性乳腺癌分子亚分类的管腔雄激素受体亚型和肿瘤浸润淋巴细胞组
Sci Rep. 2025 Mar 10;15(1):8225. doi: 10.1038/s41598-025-92281-5.
2
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification.基于三阴性乳腺癌分子分型的腔面雄激素受体亚型和肿瘤浸润淋巴细胞组。
Sci Rep. 2024 May 17;14(1):11278. doi: 10.1038/s41598-024-61640-z.
3
APOBEC-Driven Hypermutation in the Lymphocyte-Predominant Group of Triple-Negative Breast Cancer.三阴性乳腺癌淋巴细胞为主型中APOBEC驱动的高突变
Lab Invest. 2025 Apr 6;105(7):104165. doi: 10.1016/j.labinv.2025.104165.
4
Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.雄激素受体和 FOXA1 的共表达定义了一种“腔面雄激素受体”的猫乳腺肿瘤亚型，这是乳腺癌的自发模型。
BMC Cancer. 2019 Dec 30;19(1):1267. doi: 10.1186/s12885-019-6483-6.
5
IPH-926 lobular breast cancer cells are triple-negative but their microarray profile uncovers a luminal subtype.IPH-926 乳腺癌细胞为三阴性，但它们的基因芯片分析结果揭示了一个腔面亚型。
Cancer Sci. 2013 Dec;104(12):1726-30. doi: 10.1111/cas.12276.
6
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.浸润淋巴细胞与不同亚型乳腺癌患者预后的关系：新辅助化疗治疗 3771 例患者的汇总分析
Lancet Oncol. 2018 Jan;19(1):40-50. doi: 10.1016/S1470-2045(17)30904-X. Epub 2017 Dec 7.
7
A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes.三阴性乳腺癌替代亚型分类与基因表达亚型相关。
Breast Cancer Res Treat. 2022 Feb;191(3):599-610. doi: 10.1007/s10549-021-06437-8. Epub 2022 Jan 12.
8
Luminal androgen receptor (LAR) subtype of triple-negative breast cancer: molecular, morphological, and clinical features.三阴性乳腺癌的腔面雄激素受体（LAR）亚型：分子、形态和临床特征。
J Zhejiang Univ Sci B. 2022 Aug 15;23(8):617-624. doi: 10.1631/jzus.B2200113.
9
[Clinicopathological characteristics and prognosis of different molecular types of breast cancer].[不同分子类型乳腺癌的临床病理特征及预后]
Zhonghua Yi Xue Za Zhi. 2016 Jun 14;96(22):1733-7. doi: 10.3760/cma.j.issn.0376-2491.2016.22.004.
10
Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers.通过免疫组化生物标志物对三阴性乳腺癌进行分子分型和靶点鉴定。
BMC Cancer. 2025 Mar 13;25(1):454. doi: 10.1186/s12885-025-13832-7.